ERBB2 and breast cancer: It has also been shown that miR‐125b, when epigenetically modulated by lncRNA TINCR, regulates EMT via targeting Snail‐1 in trastuzumab‐resistant HER2‐positive SKBR‐3 and BT474 breast cancer cells.140